ReShape Lifesciences (RSLS) Short Interest Ratio & Short Volume → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free RSLS Stock Alerts $0.17 -0.01 (-5.56%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media ReShape Lifesciences Short Interest DataCurrent Short Volume487,800 sharesPrevious Short Volume729,300 sharesChange Vs. Previous Month-33.11%Dollar Volume Sold Short$80,238.22Short Interest Ratio / Days to Cover0.9Last Record DateApril 15, 2024Outstanding Shares13,140,000 sharesFloat Size20,810,000 sharesShort Percent of Float2.34%Today's Trading Volume318,579 sharesAverage Trading Volume292,479 sharesToday's Volume Vs. Average109% Short Selling ReShape Lifesciences ? Sign up to receive the latest short interest report for ReShape Lifesciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRSLS Short Interest Over TimeRSLS Days to Cover Over TimeRSLS Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now ReShape Lifesciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024487,800 shares $80,238.22 -33.1%2.3%0.9 $0.16 3/31/2024729,300 shares $134,482.92 +70.1%3.5%0.9 $0.18 3/15/2024428,700 shares $69,663.75 -43.3%2.1%0.4 $0.16 2/29/2024756,200 shares $127,268.46 -9.0%4.0%0.1 $0.17 2/15/2024830,800 shares $143,063.76 -3.7%4.4%0.2 $0.17 1/31/2024862,400 shares $180,327.84 -41.3%4.6%0.2 $0.21 Get the Latest News and Ratings for RSLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ReShape Lifesciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,470,000 shares $378,672.00 +102.2%14.0%0.2 $0.26 12/31/2023726,900 shares $181,506.93 -93.6%5.6%0.1 $0.25 12/15/202311,270,000 shares $3.73 million +5,386.9%86.9%1.5 $0.33 11/30/2023205,400 shares $46,851.74 -66.6%1.6%0.1 $0.23 11/15/2023614,800 shares $150,195.64 -63.2%4.7%0.2 $0.24 10/31/20231,670,000 shares $413,659.00 +77.7%14.0%0.5 $0.25 10/15/2023939,900 shares $284,601.72 +178.7%7.9%0.5 $0.30 9/30/2023337,300 shares $114,007.40 +112.8%2.8%1.5 $0.34 9/15/2023158,500 shares $118,082.50 +335.4%4.8%1.1 $0.75 8/31/202336,400 shares $33,855.64 +658.3%1.1%0.2 $0.93 8/15/20234,800 shares $5,712.00 -79.1%0.2%0 $1.19 7/31/202323,000 shares $32,660.00 +12.2%0.8%0.1 $1.42 7/15/202320,500 shares $30,750.00 -74.8%0.7%0.1 $1.50 6/30/202381,300 shares $120,324.00 +95.0%2.9%0.3 $1.48 6/15/202341,700 shares $91,740.00 -59.6%1.5%0.1 $2.20 5/31/2023103,100 shares $249,502.00 -7.9%3.7%0.4 $2.42 5/15/2023111,900 shares $275,274.00 -11.8%4.0%0.4 $2.46 6/15/2021100 shares $213.33 No ChangeN/A0.1 $2.13 5/28/2021100 shares $620.00 No ChangeN/A0.1 $6.20 4/15/2021100 shares $440.00 No ChangeN/A0.2 $4.40 3/31/2021100 shares $420.00 No ChangeN/A0.1 $4.20 2/12/20211,000 shares $9,000.00 +150.0%N/A0.3 $9.00 1/29/2021400 shares $2,486.40 +300.0%N/A0 $6.22 1/15/2021100 shares $400.00 No ChangeN/A0.1 $4.00 12/31/2020100 shares $375.00 No ChangeN/A0.2 $3.75 12/15/2020100 shares $445.00 No ChangeN/A0.1 $4.45 11/30/2020100 shares $445.00 No ChangeN/A0.5 $4.45 11/15/2020100 shares $410.00 No ChangeN/A0.1 $4.10 10/30/2020100 shares $345.00 No ChangeN/A0.1 $3.45 10/15/2020100 shares $350.00 No ChangeN/A0.3 $3.50 9/30/2020100 shares $400.00 No ChangeN/A0 $4.00 9/15/2020100 shares $325.00 No ChangeN/A0.1 $3.25 8/31/2020100 shares $468.00 No ChangeN/A0 $4.68 8/14/2020100 shares $261.00 No ChangeN/A0.1 $2.61Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. RSLS Short Interest - Frequently Asked Questions What is ReShape Lifesciences' current short interest? Short interest is the volume of ReShape Lifesciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 487,800 shares of RSLS short. 2.34% of ReShape Lifesciences' shares are currently sold short. Learn More on ReShape Lifesciences' current short interest. What is a good short interest ratio for ReShape Lifesciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RSLS shares currently have a short interest ratio of 1.0. Learn More on ReShape Lifesciences's short interest ratio. What is a good short interest percentage for ReShape Lifesciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.34% of ReShape Lifesciences' floating shares are currently sold short. Is ReShape Lifesciences' short interest increasing or decreasing? ReShape Lifesciences saw a drop in short interest in April. As of April 15th, there was short interest totaling 487,800 shares, a drop of 33.1% from the previous total of 729,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ReShape Lifesciences' float size? ReShape Lifesciences currently has issued a total of 13,140,000 shares. Some of ReShape Lifesciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ReShape Lifesciences currently has a public float of 20,810,000 shares. How does ReShape Lifesciences' short interest compare to its competitors? 2.34% of ReShape Lifesciences' shares are currently sold short. Here is how the short interest of companies compare to ReShape Lifesciences: Quoin Pharmaceuticals, Ltd. (0.42%), Nemaura Medical Inc. (0.34%), ProSomnus, Inc. (1.18%), Tenon Medical, Inc. (1.82%), Dynatronics Co. (0.58%), Bluejay Diagnostics, Inc. (0.02%), INVO Bioscience, Inc. (0.65%), Sintx Technologies, Inc. (2.44%), Minerva Surgical, Inc. (92.12%), Aethlon Medical, Inc. (1.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ReShape Lifesciences stock? Short selling RSLS is an investing strategy that aims to generate trading profit from ReShape Lifesciences as its price is falling. RSLS shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ReShape Lifesciences? A short squeeze for ReShape Lifesciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RSLS, which in turn drives the price of the stock up even further. How often is ReShape Lifesciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RSLS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: QNRX Short Interest Data NMRD Short Interest Data OSA Short Interest Data TNON Short Interest Data DYNT Short Interest Data BJDX Short Interest Data INVO Short Interest Data SINT Short Interest Data UTRS Short Interest Data AEMD Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RSLS) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe only accurate crypto trading system I know …Weiss Ratings